Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00356382Phase 3Completed
Phase 3, randomised, double-blind trial of lactobacillus casei in respiratory tract infection (RTI), gastrointestinal infection and diarrhea, sponsored by Georgetown University. Primary endpoint: Mean of sick days due to upper-respiratory and gastro-intestinal infections and diarrhea. Started Sep 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00356382.